The Lancet HIV in conversation with

Di Gibb and Anna Turkova on dolutegravir for children with HIV

August 04, 2020 The Lancet HIV
Di Gibb and Anna Turkova on dolutegravir for children with HIV
The Lancet HIV in conversation with
More Info
The Lancet HIV in conversation with
Di Gibb and Anna Turkova on dolutegravir for children with HIV
Aug 04, 2020
The Lancet HIV

Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show Notes

Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv